Chemotherapy in advanced prostate cancer

被引：0
作者：
Beedassy, A [1 ]
Cardi, G [1 ]
机构：
[1] Med Coll Penn & Hahnemann Univ, Ctr Canc, Div Hematol Oncol, Philadelphia, PA 19102 USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：428 / 438
页数：11
相关论文
共 52 条
[41]   Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer [J].
Small, EJ ;
Srinivas, S ;
Egan, B ;
McMillan, A ;
Rearden, TP .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1617-1625
[42]  
SMALL EJ, 1997, P AM SOC CLIN ONCOL, V16, pA1227
[43]  
Smith D C, 1997, Semin Urol Oncol, V15, P3
[44]   Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer [J].
Smith, DC ;
Dunn, RL ;
Strawderman, MS ;
Pienta, KJ .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1835-1843
[45]  
SMITH DC, 1993, P AN M AM SOC CLIN, V11, P213
[46]  
SPEICHER LA, 1992, CANCER RES, V52, P4433
[47]  
TANNOCK IF, 1996, J CLIN ONCOL, V14, P1556
[48]   WEEKLY DOXORUBICIN IN ENDOCRINE REFRACTORY CARCINOMA OF THE PROSTATE [J].
TORTI, FM ;
ASTON, D ;
LUM, BL ;
KOHLER, M ;
WILLIAMS, R ;
SPAULDING, JT ;
SHORTLIFFE, L ;
FREIHA, FS .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (08) :477-482
[49]  
TORTI FM, 1985, CANCER, V56, P2580, DOI 10.1002/1097-0142(19851201)56:11<2580::AID-CNCR2820561108>3.0.CO
[50]  
2-W
123456